Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Individualised dosing of commonly used anti-cancer agents

Drug-drug interactions: Focus on acid-suppressive agents

Date

30 Sep 2019

Session

Individualised dosing of commonly used anti-cancer agents

Topics

Cytotoxic Therapy

Tumour Site

Oesophageal Cancer;  Gastric Cancer;  Non-Small Cell Lung Cancer;  Colon and Rectal Cancer

Presenters

Ron Mathijssen

Authors

R.H. Mathijssen

Author affiliations

  • Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, 3075 EA - Rotterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Emiliano Calvo

Session: Individualised dosing of commonly used anti-cancer agents

Resources:

Slides

Webcast

Drug-food interactions

Presenter: Marzia Del Re

Session: Individualised dosing of commonly used anti-cancer agents

Resources:

Slides

Webcast

Optimising dosing of I-O agents

Presenter: Emiliano Calvo

Session: Individualised dosing of commonly used anti-cancer agents

Resources:

Slides

Webcast

Conclusions and perspectives

Presenter: Ron Mathijssen

Session: Individualised dosing of commonly used anti-cancer agents

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.